These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33778001)

  • 1. Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers.
    Sun S; Guo W; Lv F; Zhang G; Wang J; Li R; Tan F; Li N; Xue Q; Gao Y; Gao S; He J
    Front Mol Biosci; 2021; 8():587436. PubMed ID: 33778001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication.
    Sun S; Yang Y; Yang Z; Wang J; Li R; Tian H; Tan F; Xue Q; Gao Y; He J
    Front Cell Dev Biol; 2021; 9():743724. PubMed ID: 34746138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
    Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
    BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
    Ren Z; Hu M; Wang Z; Ge J; Zhou X; Zhang G; Zheng H
    Front Genet; 2021; 12():672904. PubMed ID: 34434214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas.
    Mao K; Tang R; Wu Y; Zhang Z; Gao Y; Huang H
    Front Genet; 2023; 14():1118273. PubMed ID: 36923797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma.
    Shen C; Wang Y
    Arch Med Res; 2023 Jan; 54(1):45-55. PubMed ID: 36528469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma.
    Ye C; Lu Y; Yuan Z; Mi M; Qi L; Yuan Y; Weng S
    Front Genet; 2022; 13():922914. PubMed ID: 36267413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma.
    Yi L; Huang P; Gu Y; Wu G; Zou X; Guo L; Wen C; Zhu J; Zhao D
    Front Oncol; 2022; 12():794293. PubMed ID: 35155238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.
    Wang Y; Fan J; Chen T; Xu L; Liu P; Xiao L; Wu T; Zhou Q; Zheng Q; Liu C; Chan FL; Wu D
    Front Endocrinol (Lausanne); 2022; 13():975623. PubMed ID: 36034466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas.
    Sun S; Fei K; Zhang G; Wang J; Yang Y; Guo W; Yang Z; Wang J; Xue Q; Gao Y; He J
    Front Genet; 2020; 11():617174. PubMed ID: 33679869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma.
    Zhang J; Wang D; Chen X; Ji L; Yu M; Guo M; Zhang D; Chen W; Xu F
    Front Genet; 2022; 13():825685. PubMed ID: 35646059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma.
    Guo Y; Qu Z; Li D; Bai F; Xing J; Ding Q; Zhou J; Yao L; Xu Q
    Cell Death Discov; 2021 Jul; 7(1):190. PubMed ID: 34312372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning revealed ferroptosis features and ferroptosis-related gene-based immune microenvironment in lung adenocarcinoma.
    Luo L; Chen X; Huang F
    Chem Biol Interact; 2023 Jun; 378():110471. PubMed ID: 37061114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types.
    Tang B; Yan R; Zhu J; Cheng S; Kong C; Chen W; Fang S; Wang Y; Yang Y; Qiu R; Lu C; Ji J
    Int J Biol Sci; 2022; 18(1):180-198. PubMed ID: 34975326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nomogram Integrating Ferroptosis- and Immune-Related Biomarkers for Prediction of Overall Survival in Lung Adenocarcinoma.
    Chai M; Li X; Zhang Y; Tang Y; Shu P; Lin J; Shi K; Wang L; Huang X
    Front Genet; 2021; 12():706814. PubMed ID: 34539740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Jia M; Yao L; Yang Q; Chi T
    Front Oncol; 2020; 10():168. PubMed ID: 32154170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma.
    Ke S; Wang C; Su Z; Lin S; Wu G
    Front Genet; 2022; 13():897683. PubMed ID: 35651950
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer.
    Zhang HC; Deng SH; Pi YN; Guo JN; Xi H; Shi X; Yang XF; Zhang BM; Xue WN; Cui BB; Liu YL
    Front Immunol; 2022; 13():855849. PubMed ID: 35444656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma.
    Lu T; Xu R; Li Q; Zhao JY; Peng B; Zhang H; Guo JD; Zhang SQ; Li HW; Wang J; Zhang LY
    Mol Ther Oncolytics; 2021 Jun; 21():134-143. PubMed ID: 33981829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.